IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 42 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,397,433 | +2086.8% | 169,851 | +1974.9% | 0.01% | – |
| Q3 2022 | $384,000 | +25.9% | 8,186 | 0.0% | 0.00% | – |
| Q2 2022 | $305,000 | +14.2% | 8,186 | 0.0% | 0.00% | – |
| Q1 2022 | $267,000 | -4.6% | 8,186 | 0.0% | 0.00% | – |
| Q4 2021 | $280,000 | -20.7% | 8,186 | -14.1% | 0.00% | – |
| Q3 2021 | $353,000 | -5.1% | 9,528 | 0.0% | 0.00% | – |
| Q2 2021 | $372,000 | -12.7% | 9,528 | -4.7% | 0.00% | – |
| Q1 2021 | $426,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $21,500,000 | 16.53% |
| Velan Capital Investment Management LP | 293,385 | $10,946,000 | 11.10% |
| Paradigm Biocapital Advisors LP | 667,417 | $24,901,000 | 4.96% |
| RTW INVESTMENTS, LP | 3,996,154 | $149,097,000 | 3.85% |
| Rock Springs Capital Management LP | 2,671,652 | $99,679,000 | 2.90% |
| TANG CAPITAL MANAGEMENT LLC | 385,600 | $14,387,000 | 2.18% |
| Samsara BioCapital, LLC | 160,963 | $6,006,000 | 1.60% |
| Avidity Partners Management LP | 1,350,000 | $50,369,000 | 1.16% |
| Pier Capital, LLC | 123,394 | $4,604,000 | 0.78% |
| Omega Fund Management, LLC | 51,535 | $1,923,000 | 0.61% |